DrugPatentWatch Database Preview
Able Company Profile
What is the competitive landscape for ABLE, and what generic and branded alternatives to ABLE drugs are available?
ABLE has sixty-two approved drugs.
Summary for Able
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 27 |
| NDAs: | 62 |
| Patent Litigation for Able: | See patent lawsuits for Able |
Drugs and US Patents for Able
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 040559-001 | Jul 22, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Able | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 076823-002 | Jun 29, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Able | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 076814-003 | Aug 25, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Able | METHAMPHETAMINE HYDROCHLORIDE | methamphetamine hydrochloride | TABLET;ORAL | 040529-001 | Feb 25, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
